Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced that it will issue its financial results for the fiscal 2019 second quarter ended March 31, 2019, following the close of market on Tuesday, April 30, 2019.
April 18, 2019
· 2 min read